Mark Kawakami - May 9, 2025 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role: Chief Financial Officer
Signature: Mark Kawakami, by Attorney-in-fact, Solaeta Chan
Stock symbol: RKDA
Transactions as of: May 9, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/12/2025, 08:56 PM
Previous filing: Feb 5, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kawakami Mark	Chief Financial Officer	C/O ARCADIA BIOSCIENCES, INC., 5950 SHERRY LANE, SUITE 215, DALLAS	Mark Kawakami, by Attorney-in-fact, Solaeta Chan	2025-05-12	0002030709

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RKDA	Stock Option (Right to Buy)	Award	$0	+12.5K	+58.17%	$0.00	34K	May 9, 2025	Common Stock	12.5K	$3.88	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.